Related Experiment Video
Updated: Dec 30, 2025
Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis
Published on: March 11, 2017
NRF-2 and nonalcoholic fatty liver disease
Arturo Solano-Urrusquieta1, José A Morales-González2, Graciela E Castro-Narro3
1Internal medicine department, Military Hospital, Mexico.
Abstract:
Currently, chronic liver diseases have conditioned morbidity and mortality, many of these with a metabolic, toxicologic, immunologic, viral, or other etiology. Thus, a transcription factor that has been of huge importance for biomedical research is NRF-2. The latter is considered a principal component of the antioxidant mechanism, and it has been acknowledged that it impairs the function of NRF-2 in many liver diseases and that it forms an essential part of the pathologic changes that occur in the liver to contain inflammation and damage. Within the investigations and experiments carried out, there are isolated drugs, many of them related to plants and natural extracts that possess antioxidant properties through the NRF-2 signaling pathway, or even involving the stimulation of the transcription target proteins of NRF-2. Notwithstanding all of these experimental findings, to date there is not sufficient clinical evidence to justify the use of NRF-2 in medical practice.
Insights
Nuclear factor erythroid 2-related factor 2 (NRF-2) plays a key role in liver disease antioxidant defense. While natural compounds show promise in modulating NRF-2, clinical evidence for its therapeutic use remains insufficient.
Area of Science:
- Hepatology
- Molecular Biology
- Biomedical Research
Background:
- Chronic liver diseases contribute significantly to morbidity and mortality.
- Nuclear factor erythroid 2-related factor 2 (NRF-2) is a critical transcription factor in the body's antioxidant defense system.
- NRF-2 pathway dysfunction is implicated in the pathology of various liver diseases, including inflammation and damage.
Purpose of the Study:
- To review the role of NRF-2 in chronic liver diseases.
- To explore natural compounds and their mechanisms targeting the NRF-2 pathway for potential therapeutic benefits.
- To assess the current clinical evidence supporting NRF-2 modulation in liver disease treatment.
Main Methods:
- Literature review of studies investigating NRF-2 in liver disease.
- Analysis of research on natural products and extracts affecting NRF-2 signaling.
- Evaluation of existing clinical trial data related to NRF-2 interventions.
Main Results:
- NRF-2 function is impaired in many chronic liver diseases, contributing to pathological changes.
- Numerous natural compounds and plant extracts demonstrate antioxidant properties via NRF-2 pathway modulation.
- Experimental studies show these compounds can stimulate NRF-2 target proteins.
Conclusions:
- The NRF-2 pathway is a significant target for managing liver disease.
- Natural products offer a promising avenue for NRF-2-mediated liver protection.
- Substantial clinical evidence is still lacking to support NRF-2 therapeutic applications in medical practice.
More Related Videos
08:35A Model of Experimental Steatosis In Vitro: Hepatocyte Cell Culture in Lipid Overload-Conditioned Medium
Published on: May 18, 2021
08:41Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease
Published on: March 24, 2023
Related Concept Videos
01:31Transducer Mechanism: Nuclear Receptors
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
01:25Ultrasound II: Endoscopic Ultrasound and FibroScan
Endoscopic Ultrasound (EUS):
02:26NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...